文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

COVID-19对伦敦西北部基层医疗抗生素处方的影响

Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves.
PubMed 文献 · Clin Microbiol Infect · 2021-02-16

OBJECTIVES: We investigated the impact of COVID-19 and national pandemic response on primary care antibiotic prescribing in London. METHODS: Individual prescribing records between 2015 and 2020 for 2 million residents in north west London were analysed.…

要点

  • 2020年3月后基层抗生素处方下降速率由584项/月加速至3504项/月并持续。
  • 50岁及以上人群中co-amoxiclav处方在2020年2至4月上升70.1%。
  • SARS-CoV-2阳性后14天内常用阿莫西林(34.9%)和多西环素(27.4%)。

核心结论

  • 自首次封锁以来观察到社区抗生素处方持续减少,需紧急调查社区感染及处方减少的潜在非预期后果。

主要发现

  • 2020年3月前基层抗生素处方存在每月减少584项的背景下降趋势,2020年3月起减少速率加速至每月3504项。
  • 该下降速率在初始高峰后持续,延续至冬季和第二波疫情。
  • 尽管总体处方量下降,50岁及以上人群co-amoxiclav处方从2月至4月上升70.1%。
  • SARS-CoV-2阳性后14天内常用抗生素为阿莫西林(863/2474,34.9%)和多西环素(678/2474,27.4%),与原因不明的社区肺炎国家指南一致。

关键数值与推荐

  • 2020年3月前背景下降趋势为每月减少584项,2020年3月起加速至每月3504项。
  • 50岁及以上人群co-amoxiclav处方2020年2至4月上升70.1%。
  • SARS-CoV-2阳性后14天内阿莫西林使用863/2474(34.9%),多西环素678/2474(27.4%)。
  • COVID-19高峰期间「Watch」类抗生素使用比例下降。

临床怎么用

  • 提示疫情封锁后基层抗生素处方持续下降,应关注社区感染诊断与处方减少的非预期后果。

局限性

  • 原文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We investigated the impact of COVID-19 and national pandemic response on primary care antibiotic prescribing in London. METHODS: Individual prescribing records between 2015 and 2020 for 2 million residents in north west London were analysed. Prescribing records were linked to SARS-CoV-2 test results. Prescribing volumes, in total, and stratified by patient characteristics, antibiotic class and AWaRe classification, were investigated. Interrupted time series analysis was performed to detect measurable change in the trend of prescribing volume since the national lockdown in March 2020, immediately before the first COVID-19 peak in London. RESULTS: Records covering 366 059 patients, 730 001 antibiotic items and 848 201 SARS-CoV-2 tests between January and November 2020 were analysed. Before March 2020, there was a background downward trend (decreasing by 584 items/month) in primary care antibiotic prescribing. This reduction rate accelerated to 3504 items/month from March 2020. This rate of decrease was sustained beyond the initial peak, continuing into winter and the second peak. Despite an overall reduction in prescribing volume, co-amoxiclav, a broad-spectrum "Access" antibiotic, prescribing rose by 70.1% in patients aged 50 and older from February to April. Commonly prescribed antibiotics within 14 days of a positive SARS-CoV-2 test were amoxicillin (863/2474, 34.9%) and doxycycline (678/2474, 27.4%). This aligned with national guidelines on management of community pneumonia of unclear cause. The proportion of "Watch" antibiotics used decreased during the peak in COVID-19. DISCUSSION: A sustained reduction in community antibiotic prescribing has been observed since the first lockdown. Investigation of community-onset infectious diseases and potential unintended consequences of reduced prescribing is urgently needed.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Zhu N, Aylin P, Rawson T, et al. Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves. Clin Microbiol Infect. 2021. PMID: 33601010. doi:10.1016/j.cmi.2021.02.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。